Quadessy delivers multi-layer skin remodeling through a unique tip and dual-depth design
A Digital Publication for the Practicing Medical Specialist, Industry Executive and Investor
Medical Device News Magazine is committed to delivering high‑quality, in‑depth medical device news and biotechnology updates that include expert bylines. Our coverage offers a comprehensive view of the trends, innovations, and breakthroughs shaping the future of medical technology.
We also strive to provide a distinctive perspective on the rapidly evolving healthcare landscape. By staying connected with our reporting, you gain access to exclusive insights on industry developments, emerging technologies, and global regulatory changes that influence the medical device sector. At the same time, you join a vibrant community of professionals, innovators, and thought leaders dedicated to advancing healthcare through cutting‑edge solutions.
We invite you to explore our wide range of content—from the latest product announcements to detailed analyses of industry trends. And if our mission aligns with your goals, we offer opportunities for advertising and collaboration, helping you connect with a highly engaged audience of medical technology professionals.
Definition medical devices.
Quadessy delivers multi-layer skin remodeling through a unique tip and dual-depth design
Medtronic's latest partnership with Merit Medical Systems introduces the groundbreaking ViaVerte™ BVNA system—an innovative solution for chronic vertebrogenic pain
Led by researchers at the Vanderbilt University Medical Center, a new study reports that Optellum's FDA-cleared Lung Cancer Prediction (LCP) AI assisted risk stratification for indeterminate lung nodules is cost-effective from a US payer perspective. Optellum's LCP AI supports more consistent long nodule management and helps enable earlier diagnosis of...
First patient dosed in Opti-GAIN, a first-in-human Phase I/II clinical trial of CTx001 in Geographic Atrophy secondary to AMD
The study, published in The March 2026 edition of Federal Practitioner, reported an association between thermal therapy use and reduced opioid and benzodiazepine utilization, as well as lower healthcare utilization in the patient population.
The Journal of the American Medical Association (JAMA Neurology) publication highlights consistent clinical and biomarker findings from NeuroSense PARADIGM Phase 2b trial in ALS, including slower functional decline, reduced risk of ALS-related complications, and modulation of disease-relevant biomarkers
Joint initiative with Rosebud Biosciences, Kantify, and funded by Incite will identify and quantify off-target toxicities in chemotherapy patients
Robust DNA extraction supports earlier detection and diagnosis of colorectal cancer and other gastrointestinal diseases
Redipor® Legionella agar plate range - specifically designed to support the detection and enumeration of Legionella in water samples
As part of the transaction, HealthMark management and existing investor Ridgemont Equity Partners will both roll meaningful ownership stakes, welcoming TA as the new lead investor. Financial terms of the transaction were not disclosed.
Aidoc’s $150M funding will enhance clinical AI solutions, impacting 100 million patients’ care and decision-making processes.

“The way we think about healthcare is evolving rapidly. From AI-assisted diagnostics to telehealth expansion, technology is breaking down barriers and reshaping how people access essential medical services. In eyecare, artificial intelligence is increasingly redefining accessibility, affordability, and accuracy in vision care,” writes Matthias Hofmann.

While virtual reality in telehealth might seem like a novel technology to incorporate into healthcare, at least one portion of our field has been using it for 250 years. Simulation technology has long been instrumental in medical training since it makes failure safe while students practice key skills.

According to recent research, 15% of the global population over the age of 30 is affected by osteoarthritis, or OA, the most common form of arthritis. This same study projects that OA will affect nearly 1 billion people by the year 2050. These statistics show that OA is a pressing medical concern that should be a top priority for medical professionals seeking to improve their patients’ quality of life.
This designation is for the treatment of adult patients with advanced, unresectable or metastatic nonsquamous non-small cell lung cancer (nsqNSCLC) with an EGFR exon 19 deletion or L858R mutation with disease progression on or after treatment with a third-generation EGFR tyrosine kinase inhibitor (TKI) and platinum-based chemotherapy.
IDE approval in both countries follows strong feasibility clinical results in France.

Sam Ricchezza is the latest addition to an executive team tasked with continuing the CMO’s recent growth trends.
Appointment highlights Cardiosense’s growth trajectory following FDA clearance, clinical milestones, and expanded leadership team

This promotion reflects HOMELINK’s commitment to operational excellence and leadership continuity, as she continues to oversee the company’s Operations teams for both workers’ compensation and group health

The Reveal Mobi Pro ™ integrates KA Imaging’s Reveal™ 35C detector with SpectralDR® technology into a complete mobile X-ray solution.

With FDA clearance of SubtleHD™, Subtle Medical launches Subtle-ELITE™, an industry-first AI package designed to achieve superior image quality, unprecedented speed, and workflow automation.

“This program is saving lives, reducing disability, and changing the futures of stroke patients,” said Dr. Dmytro Lebedynets, a neurologist at Feofaniya Clinical Hospital and consultant on stroke to the World Bank and the Ministry of Health of Ukraine. “With these advanced tools, we can deliver timely and precise life-saving care, even in emergencies. It’s a game-changer for our patients. Now all the regions of our country will be able to provide the full spectrum of care to stroke patients.”

This discovery could lead to new treatments to prevent heart failure, a serious cardiac condition that develops in up to 30% of heart attack survivors within one year.
Smart hospitals are at the forefront of a global transformation in healthcare, integrating advanced technologies to improve patient outcomes, enhance operational efficiency, and reduce costs.

Trust is now the most valuable asset in healthcare digital marketing

In medicine, material science, or environmental research, chemicals are the building blocks of significant progress

If you’ve ever watched a medical device rep dart between hospitals, you know the job isn’t just about pitching a product. They’re up before sunrise,

In the competitive field of medical technology, the business of launching a new device is multifaceted
Medical Device News Magazine uses cookies to improve your experience on our site. By using our site, you consent to cookies.
Manage your cookie preferences below:
Essential cookies enable basic functions and are necessary for the proper function of the website.
Google Tag Manager simplifies the management of marketing tags on your website without code changes.
You can find more information in our Cookie Policy: Medical Device NewsMagazine and PRIVACY.